Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: A randomised trial
J. W. Van Werkum*, W. B.M. Gerritsen, J. C. Kelder, C. M. Hackeng, S. M. Ernst, V. H.M. Deneer, M. J. Suttorp, B. J.W.M. Rensing, H. W.M. Plokker, J. M. Ten Berg
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: A randomised trial'. Together they form a unique fingerprint.